Dictionary

The Dictionary provides concise definitions of health economics terms, arranged alphabetically for quick reference. Use it to understand unfamiliar terminology or confirm the meaning of a specific term.

551–600 of 666 terms matching “Cost”

P

Preferred DrugFirst-Line Formulary Choice, Favoured Formulary Agent
A medication assigned to a lower-cost formulary tier, typically with lower patient cost-sharing, to encourage its use over costlier alternatives.
Preferred Provider OrganizationPPO, Preferred-Network Plan
A managed care plan offering a discounted contracted network while still allowing out-of-network care at higher cost-sharing, without requiring referrals.
Premium SubsidyInsurance Subsidy, Premium Assistance
Financial assistance provided by a government to reduce health insurance premium costs for eligible individuals or households.
PrepaymentAdvance Payment, Prepaid Financing
A financing mechanism in which individuals contribute funds toward future healthcare costs before they are incurred, through taxation or premiums.
Present BiasPresent Bias Concept, Current-Moment Bias
The tendency to place disproportionate weight on immediate rewards or costs relative to future ones, beyond what constant discounting predicts.
Price CutMandated Price Decrease, Price Lowering
A reduction in a drug's price, whether voluntary or mandated, affecting a treatment's ongoing cost-effectiveness and overall budget impact.
Price Elasticity of ICERICER Price Sensitivity, ICER Elasticity
A measure of how sensitively a treatment's ICER responds to price changes, used to identify the price at which it crosses a cost-effectiveness threshold.
Price GrowthPrice Increase, Price Rise
The component of rising healthcare expenditure attributable to increases in input prices, such as wages or drug costs, rather than volume or intensity.
Price ProtectionPrice Guarantee, Price-Increase Cap
A contractual clause limiting or preventing future price increases beyond an agreed threshold for a specified period, giving payers cost certainty.
Prior UtilisationPrior Use, Previous Utilisation
An individual's past pattern of healthcare service use, commonly used as a predictor within risk adjustment models of future costs.
Priority SettingPrioritisation, Rationing Decisions
The systematic process of deciding how to allocate limited health resources across competing needs, informed by cost-effectiveness and equity.
Priority Setting CoverageCoverage Prioritisation, Priority-Based Coverage
The process by which a payer determines which services are included within a covered benefits package, informed by cost-effectiveness and evidence.
Private Discount RateIndividual Discount Rate, Market Discount Rate
The rate at which an individual personally discounts future costs and benefits, typically higher than the social discount rate used in policy evaluation.
Private Insurance PremiumCommercial Insurance Premium, Private Cover Premium
The periodic payment an individual or employer makes to a private insurer in exchange for coverage of specified healthcare costs.
Private Sector PerspectiveCommercial Viewpoint, Industry Standpoint
An analytic viewpoint including only costs and outcomes relevant to private organisations, such as insurers or employers, excluding costs borne by public payers.
Producer TheoryTheory of the Firm, Supply-Side Theory
The branch of microeconomic theory analysing how firms choose inputs and output levels to maximise profit given their costs and market conditions.
Programme PerspectiveProgram Perspective, Intervention-Programme Viewpoint
An analytic viewpoint defined by the boundaries of a specific programme, including all costs and outcomes attributable to it regardless of the broader payer.
Prospective EvaluationForward Evaluation, Concurrent Evaluation
An economic evaluation in which cost and outcome data are collected forward in time from the study's start, unlike a retrospective evaluation.
Prospective PaymentPPS, Fixed Prospective Rate
A methodology establishing a fixed reimbursement in advance of care delivery, based on diagnosis or procedure type, rather than actual incurred costs.
Psychiatric Hospital EconomicsInpatient Psychiatric Economics, Mental Hospital Economics
The application of health economic evaluation to inpatient psychiatric facilities, comparing cost and outcomes against community-based alternatives.
Public Sector PerspectiveGovernment-Sector Viewpoint, State Analytic Perspective
An analytic viewpoint including costs and outcomes relevant to government budgets, potentially spanning multiple public agencies rather than a single health payer.
Purchasing Power ParityCommon-Basket Comparison, International Price Comparison
A method of comparing economic value across countries based on the relative cost of a common basket of goods and services, rather than exchange rates.

R

RAND Health Insurance ExperimentRAND HIE, Health Insurance Experiment
A large randomised US experiment assigning families to insurance plans with varying cost-sharing levels, providing key evidence on how price affects healthcare use.
Rate AdjustmentRate Correction, Adjusted Rate Method
A modification to an existing payment rate, up or down, implemented to reflect changes in costs or policy priorities.
Real-World ValueRoutine-Practice Value, Observed Value in Practice
An assessment of a technology's actual benefit and cost-effectiveness observed under routine clinical practice, unlike trial-based efficacy value estimates.
RebateManufacturer Discount, Volume Concession
A retrospective payment from a manufacturer to a payer, typically a percentage of price or based on utilisation volume, reducing true net cost.
Reduced ConsumptionConsumption Reduction, Demand Reduction
A coping strategy where a household cuts spending on other essentials, such as food, to cover healthcare costs, indicating financial strain.
Regional PerspectiveRegional Viewpoint, Devolved Perspective
An analytic viewpoint considering costs and outcomes relevant to a defined geographic region within a country, rather than the health system as a whole.
Registry TrialRegistry-Based Trial, Register-Embedded Study
A trial embedded within an existing disease or procedure registry to identify participants, randomise treatment, and collect outcome data at lower cost.
Reimbursement RestrictionFunding Restriction, Restricted Coverage
A coverage limitation, such as restricting a treatment to a patient subgroup or requiring prior therapy failure, to manage cost or ensure appropriate use.
Reinsurance DesignReinsurance Structure, Cession Arrangement
The specific structure of a reinsurance arrangement, including the attachment point and the proportion of costs above it the reinsurer covers.
Resource ReallocationResource Shifting, Fund Redeployment
The process of shifting resources from lower-value to higher-value uses, informed by comparative cost-effectiveness evidence, the core of priority setting.
Resource ValuationInput Valuation, Resource Pricing
The process of assigning a monetary value to a measured quantity of resource use, typically by multiplying it by a unit cost.
Respiratory Disease BurdenLung Disease Burden, Respiratory Morbidity Burden
The total impact of respiratory diseases on a population, covering mortality, morbidity, and healthcare costs, commonly quantified using disability-adjusted life years.
Results ExportResults Output, Data Export
The process of transferring a model's calculated outputs, such as cost-effectiveness results, out of its software environment for further use.
Retrospective Risk AdjustmentRetro Risk Adjustment, Concurrent-Year Adjustment
A risk adjustment method calculating payment adjustments after a coverage period ends, based on actual observed diagnoses and costs.
Return on InvestmentROI, Investment Return
Return on investment is a monetary measure of the gain attributable to an intervention relative to its investment cost, calculated under an explicitly stated benefit, cost, time, and ratio convention.
Risk AdjustmentRisk-Adjusted Payment, Morbidity Adjustment
Risk adjustment makes outcomes, costs, utilisation or payments more comparable by accounting for differences in characteristics that affect expected results but are not the focus of the comparison.
Risk ClassificationRisk Categorisation, Risk Grouping
The process of categorising individuals by expected healthcare costs or risk level, used as an input to pricing or risk adjustment.
Risk PoolInsurance Pool, Pooled Group
The group whose healthcare costs are collectively financed through a shared insurance arrangement, with premiums covering those who become ill.
Risk Sharing DesignRisk-Sharing Structure, Sharing Arrangement Design
The specific structure of a risk-sharing arrangement, including the threshold at which sharing begins and the proportion of costs each party bears above it.
Rule of RescueRescue Principle, Identifiable Victim Effect
An ethical intuition describing the strong societal impulse to devote resources to rescuing identifiable individuals in immediate danger, even against cost-effectiveness logic.

S

Scatter PlotScatter Diagram, Scattergram, Scatter Chart
A graphical display showing individual data points along two axes, commonly used to plot probabilistic sensitivity analysis results on the cost-effectiveness plane.
Screening EconomicsEconomics of Screening, Early-Detection Economics
The economic assessment of a screening programme’s full pathway, comparing its costs, health benefits, harms, budget implications and opportunity costs with feasible alternatives.
Sepsis EconomicsEconomics of Sepsis, Septicaemia Economics
The application of health economic evaluation to sepsis, a life-threatening infection response condition with substantial mortality and intensive care costs.
Service Line BudgetClinical Service Budget, Service-Line Budgeting
A budget allocated to a specific clinical service line, such as cardiology, covering its costs and expected revenues.
Severity ModifierSeverity Weight, Severity Adjustment Factor
An adjustment to a standard cost-effectiveness threshold permitting a higher accepted cost per QALY for treatments addressing more severe conditions.
Shadow PriceImplicit Price, Accounting Price
The implicit value of a resource with no observable market price, reflecting the opportunity cost of using it in a particular way.
Shared SavingsSavings Sharing, Savings Distribution
An arrangement in which a provider receives a portion of cost savings achieved relative to a predetermined spending benchmark for a population.
Signaling TheoryTheory of Signalling, Spence Signalling
A body of theory analysing how individuals with private information take costly actions to credibly reveal it in markets with information asymmetry.